Statins may lower risk of cancer-related death in women
the ONA take:
According to results of a large study presented at the 2015 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois, researchers have found that women who take statins, medications used to treat hyperlipidemia, may have a decreased risk for cancer-related death.
For the 15-year study, researchers followed nearly 150,000 post-menopausal women aged 50 to 79 years. Over that period, more than 3,100 women died of cancer. Results showed that women who took statins had a reduced risk of dying from breast, colorectal, and ovarian cancers, but not lung cancer.
Researchers found that patients who took statins were 20% less likely to die from cancer during the study duration; however, they caution that this study does not prove a causal effect that statins reduce the lower the risk cancer-related mortality.
Further studies are warranted to determine whether it would be beneficial for women with cancer to be prescribed statins to reduce their risk of death.
Women who take statins, medications used to treat hyperlipidemia, may have a decreased risk for cancer-related death.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|